News & Updates
Filter by Specialty:
Show Multimedia Only

AD trial: Cognitive impairment exacerbated with reduced iron in brain
14 Nov 2024
byJairia Dela Cruz
Brain iron-lowering therapy with deferiprone appears to do more harm than good in patients with Alzheimer's disease (AD), being associated with increased cognitive decline in a phase II study.